InternationalUSRemember you can easily switch between MIP US and MIP International at any time

SPCs in the spotlight: Court of Justice of the EU rules in Neurim on Thursday

Emma Barraclough, London


The Court of Justice of the EU will rule in a dispute between Neurim Pharmaceuticals and the UK Intellectual Property Office on Thursday, clarifying whether pharmaceutical companies can obtain supplementary protection certificates (SPCs) for second medical use patents. Here’s the background to the case

Click here for the latest on this story.

How it began

At the end of 2009, a hearing officer at the UKIPO refused an SPC for its product Ciracadin (melatonin). Circadin is used to treat insomnia and the basic patent...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements